We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GlaxoSmithKline (GSK) has filed a patent infringement lawsuit in federal court
against Spectrum Pharmaceuticals to prevent Spectrum from developing a generic
version of GSK's migraine drug Imitrex.
The pharmaceutical markets of the 10 European Union (EU) member countries added
to the EU in 2004 have been rapidly expanding in recent years, despite more
subdued growth in the rest of the region, according to a new research report.
Although Merck has not yet divulged its intentions
regarding the future of Vioxx, pharmaceutical analysts expect the drugmaker
to reintroduce the controversial arthritis pain treatment sometime this fall,
following the favorable recommendation issued recently by an FDA advisory panel.
Pharmaceutical benefit manager (PBM) Medco Health Solutions has agreed to acquire
Accredo Health for $2.2 billion -- a deal that would create the nation's largest
specialty pharmacy business, Medco has announced.
Large Scale Biology (LSBC) and Icon Genetics (ICON) have entered into a collaborative
agreement to co-develop a biopharmaceutical product for a major therapeutic
market.
Agro-pharma firm Hikal is setting up a contract research facility in Pune, Maharashtra,
with an upfront investment of Rs 20 crore ($4.5 million) for chemistry and life
sciences.
Britain's cost-effectiveness health watchdog said Tuesday it wants to limit
access to the four main drugs used to treat patients with Alzheimer's disease,
to the fury of pharmaceutical manufacturers.
Britain said on Tuesday it was buying 14.6 million courses of Roche Holding
AG's antiviral drug Tamiflu as part of its contingency plan against an influenza
pandemic.
Targacept, a central nervous system-focused biopharmaceutical company, announced
that it has postponed its previously announced initial public offering due to
unfavorable market conditions.
GenPath Pharmaceuticals, a drug discovery and development company focused on
the treatment of cancer and other diseases, announced that it has changed its
corporate name to AVEO Pharmaceuticals.